. Conclusion. CPEC could be propagated horizontally from patient to patient and possibly by plasmid dissemination. Strict infection control is necessary to prevent the spread of CREC.
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No reported disclosures. October 5, 2017: 12:30 PM Background. Pseudomonas aeruginosa (PA) is a leading cause of nosocomial infections. Multi-drug-resistant (MDR) PA is an increasing problem. The study objectives were to estimate PA prevalence in hospitalizations, rates of MDR PA and carbapenem-resistant (CR) PA, incremental hospital length of stay (LOS), and hospital cost attributable to MDR PA and CR PA.
Antimicrobial Resistance and Attributable Burden of Pseudomonas aeruginosa in Hospitalized Patients
Methods. This retrospective cohort study identified hospitalizations for MDR and CR PA with available diagnosis, laboratory, and medication data from October 1, 2013 to September 30, 2015 using the Cerner Health Facts ® database. Hospitalizations with LOS <24 hours or >3x the SD of the cohort mean were excluded. MDR was defined as intermediate or resistant to at least one drug in 3 of 5 classes: aminoglycosides, extended spectrum cephalosporins, fluoroquinolones, carbapenems, and piperacillin or piperacillin-tazobactam. CR was defined as intermediate or resistant to meropenem or imipenem. Hospitalizations for MDR and non-MDR PA and for CR and non-CR PAwere matched 1:1 by propensity score. Mean (SD) and median LOS (days) and total hospital cost (US $) were reported.
Results. A total of 1,045,038 hospitalizations were identified. The average patient age was 50 (SD = 27) and 57.5% were female. PA prevalence was 10.8/1,000 hospitalizations. Among hospitalizations for PA, the MDR rate was 12.3% and the CR rate was 14.5%. MDR and CR rates were higher in ICU (19.0% and 20.1%) than non-ICU hospitalizations (11.6% and 13.9%). Hospital LOS and total cost were significantly higher for the MDR PA group than the non-MDR PAgroup. Similarly higher LOS and total cost were observed in the CR group.
Conclusion. Our findings highlight the high rates of PA, particularly in the ICU, and the substantial economic burden associated with MDR and CR PA. Decisionmakers must evaluate optimal treatment strategies and antimicrobial stewardship measures to minimize the economic impact of these infections and improve clinical outcomes in hospitalized patients. Background. Carbapenem-resistant Enterobacteriaceae (CRE) are a group of multidrug-resistant bacteria that cause ~9,000 infections annually; ~50% of CRE bloodstream infections are fatal. The use of contact precautions (CP) for CRE patients can prevent transmission. To improve CRE surveillance and interfacility communication about positive patients, Illinois implemented the extensively drug-resistant organism (XDRO) registry in 2013. Healthcare facilities must report a patient's first positive CRE culture per stay ≤7 days from culture confirmation. Facilities can query the registry at patient admission to identify CRE status and implement transmission precautions. We assessed facility timeliness of reporting and querying frequency and registry usefulness in identifying patients who should be on CP.
Methods. We analyzed Chicago XDRO data for November 2013-October 2016. Variables were facility type (hospital, long-term acute care hospital [LTACH] , and skilled nursing facility [SNF]), culture date, and report date. Timeliness was time from culture collection to reporting. Nine facilities (2 hospitals, 4 LTACHs and 3 SNFs) completed a survey on querying frequency; all but 1 LTACH provided single day census and contact precaution lists. We compared these with the XDRO registry to identify CRE patients for whom querying would have initiated CP use.
Results. Chicago facilities reported 2,469 CRE cases. Median timeliness varied by facility type (hospitals: 8 days; SNF: 10 days; and LTACH: 55 days). Of patients on CP for CRE but not reported to the registry, 11/12 (92%) were in LTACHs. Reported querying frequency was daily for 1 hospital and rarely for other facilities. Overall, 91 patients at 8 facilities were in the registry; of these, 0/1 (0%) hospital, 3/27 (11%) LTACH, and 28/63 (44%) SNF patients were not on CP.
Conclusion. Timeliness of reporting CRE patients to the XDRO registry varied by facility type and exceeded the 7-day timeframe. Routine registry querying can identify CRE patients who should be on CP. Querying was uncommon in surveyed facilities, identifying an opportunity to improve transmission precautions among CRE patients, particularly in SNFs. We recommend facilities report cases in a timely manner and query the registry at patient admission. October 5, 2017: 12:30 PM Background. Antibiotic resistance is considered as one of our greatest emerging public health threats. Current understanding of the factors governing spread of antibiotic-resistant organisms and mechanisms among populations is limited.
Methods. We explored the roles of local temperature, population density, and additional factors on the distribution of antibiotic resistance across the United States, using a database of regional antibiotic resistance that incorporates over 1.6 million bacterial pathogens from human clinical isolates over the years 2013-2015. Results. We identified that increasing local temperature as well as population density were associated with increasing antibiotic resistance in common pathogens. An increase in temperature of 10 o C was associated with increases in antibiotic resistance of 4.2%, 2.2%, and 3.6% for the common pathogens Escherichia coli, Klebsiella pneumoniae, and Staphylococcus aureus. The effect of temperature on antibiotic resistance was robust across almost all classes of antibiotics and pathogens and strengthened over time.
Conclusion. These findings suggest that current forecasts of the burden of antibiotic resistance could be significant underestimates in the face of a growing population and warming planet. 
